X4 Pharmaceuticals (XFOR) Inventory Average (2024 - 2025)
X4 Pharmaceuticals posted quarterly Inventory Average of $4.3 million for Q4 2025, up 62.66% year-on-year from $2.6 million in Q4 2024, and up 18.06% on a QoQ basis from $3.6 million in Q3 2025.
X4 Pharmaceuticals (XFOR) has 2 years of Inventory Average data on file, last reported at $4.3 million in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average rose 62.66% year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2025 stood at $4.3 million (up 62.66% YoY), and the FY2025 full-year result was $3.6 million, changed N/A from the prior year.
- Inventory Average for Q4 2025 stood at $4.3 million, up from $3.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $4.3 million in Q4 2025 and bottomed at $1.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | 4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 3.13 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 1.64 Mn |